# Eval Results: quality-nonconformance

**Mode:** Baseline (No Capability Context)  
**Version:** 1.0.0  
**Model:** claude-sonnet-4-20250514  
**Timestamp:** 2026-02-25T07:37:51Z  
**Aggregate Score:** 83.7%  
**Passed (>=70%):** 21/26

## Summary by Difficulty

| Difficulty | Avg Score | Count |
|---|---|---|
| Easy | 80.3% | 8 |
| Medium | 81.1% | 9 |
| Hard | 89.4% | 9 |

## Summary by Category

| Category | Avg Score | Count |
|---|---|---|
| capa-management | 100.0% | 2 |
| cost-of-quality | 83.8% | 2 |
| incoming-inspection | 61.3% | 2 |
| ncr-disposition | 61.9% | 4 |
| regulatory-compliance | 76.2% | 4 |
| root-cause-analysis | 90.0% | 4 |
| spc-interpretation | 96.2% | 4 |
| supplier-quality | 97.5% | 4 |

## Scenario Details

### QNC-001: Incoming inspection lot rejection on standard dimension

**Difficulty:** easy | **Category:** incoming-inspection | **Score:** 75.0%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| lot_disposition | 0.3 | pass | 1.0 |
| inspection_level_adjustment | 0.25 | fail | 0.0 |
| scar_decision | 0.25 | pass | 1.0 |
| communication | 0.2 | pass | 1.0 |

**lot_disposition:** Agent correctly identifies that 3 defectives exceeds the accept number of 1 and properly rejects the lot per ANSI/ASQ Z1.4 standards. States 'With 3 defective parts found against an accept number of 1 (Ac=1, Re=2), the lot fails the acceptance criteria and must be rejected.' This demonstrates correct understanding of AQL sampling plan application.

**inspection_level_adjustment:** Agent incorrectly switches to tightened inspection after a single lot rejection, stating 'Move from Normal Inspection (Level II) to Tightened Inspection (Level II).' This violates ANSI/ASQ Z1.4 switching rules, which require 2 of 5 consecutive lots to be rejected before switching to tightened inspection. A single rejection only breaks the consecutive acceptance streak but does not trigger tightened inspection.

**scar_decision:** Agent correctly determines SCAR is not warranted, stating 'A Supplier Corrective Action Request (SCAR) is not warranted at this time' and provides sound reasoning: single lot failure after 12 consecutive acceptances, non-safety-critical application, marginal defects, and good supplier track record. This demonstrates appropriate escalation judgment for supplier management.

**communication:** Agent provides comprehensive communication plan including: (1) supplier notification with inspection data, root cause request, and containment actions, with specific example letter content mentioning actual measurements (25.08, 25.07, 25.06mm), and (2) internal notifications to production planning about lot rejection/delivery delay, inventory checks, quality team briefing on inspection requirements, and purchasing coordination for replacement lot.

---

### QNC-002: Simple NCR for cosmetic defect on non-critical part

**Difficulty:** easy | **Category:** ncr-disposition | **Score:** 20.0%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| disposition_decision | 0.4 | partial | 0.5 |
| capa_decision | 0.3 | fail | 0.0 |
| customer_notification | 0.3 | fail | 0.0 |

**disposition_decision:** The agent correctly identifies 'USE AS IS' disposition and notes that interior surfaces have no cosmetic specification and parts meet dimensional requirements. However, the response lacks the critical requirement for engineering concurrence documentation that would be needed for proper NCR closure. The agent states the rationale but doesn't mention the formal engineering review/concurrence process required for use-as-is dispositions, even when technically conforming.

**capa_decision:** The agent recommends initiating a CAPA for what is essentially a cosmetic observation on an unspecified surface that doesn't violate any drawing requirement. This is a classic over-reaction - treating a non-conformance to an unspecified requirement as if it were a specification violation. The 7.5% rate cited is irrelevant when there's no specification being violated. The correct approach would be process monitoring/improvement, not a formal CAPA.

**customer_notification:** The agent recommends notifying the customer about parts that fully conform to all drawing specifications, which could create unnecessary concern and potentially delay the critical 3-day delivery. The agent states notification is 'OPTIONAL' but then recommends doing it anyway, failing to recognize that notifying customers about non-issues can damage supplier credibility and create operational complications without technical justification.

---

### QNC-003: Basic SPC chart interpretation with out-of-control signal

**Difficulty:** easy | **Category:** spc-interpretation | **Score:** 100.0%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| signal_identification | 0.35 | pass | 1.0 |
| response_appropriateness | 0.35 | pass | 1.0 |
| process_understanding | 0.3 | pass | 1.0 |

**signal_identification:** The agent correctly identifies Test 2 (Nelson Rule 2) violation with 9 consecutive points above the center line, noting this indicates special cause variation and an upward shift in process mean. Correctly states the probability < 0.004 of occurring by chance and notes the R-Chart is stable, demonstrating understanding that only the mean has shifted, not the variation.

**response_appropriateness:** The agent recommends appropriate investigation into special causes (grinding wheel condition, coolant, fixtures, tool changes) without overreacting by stopping production. Correctly notes the process remains capable (Cpk 1.42) and within specification. Recommends controlled process adjustment after identifying the cause and temporarily increasing monitoring frequency, which are all appropriate responses to a mean shift signal.

**process_understanding:** Demonstrates strong process understanding by connecting the upward mean shift to likely grinding process causes (wheel wear, thermal effects, machine calibration). Correctly interprets Cpk of 1.42 as still meeting IATF 16949 requirements but notes margin is decreasing. Shows understanding of automotive manufacturing requirements and control plan reaction protocols.

---

### QNC-004: Writing a 5 Whys root cause analysis for a straightforward process failure

**Difficulty:** easy | **Category:** root-cause-analysis | **Score:** 100.0%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| five_whys_quality | 0.3 | pass | 1.0 |
| containment_actions | 0.35 | pass | 1.0 |
| corrective_action | 0.35 | pass | 1.0 |

**five_whys_quality:** The 5 Whys analysis reaches a systemic root cause rather than stopping at the surface level. The chain progresses logically: drift occurred → no interim verification → no risk-based calibration intervals → program lacks risk-based approach. Each 'why' builds toward identifying the systemic gap in the calibration program methodology. The root cause correctly identifies that the calibration program lacks a risk-based approach considering usage intensity and application criticality, which is the systemic issue that needs to be addressed.

**containment_actions:** The response properly recognizes this as a measurement system failure affecting 4,500 medical device assemblies and implements appropriate containment. Key actions include: (1) quarantining all 4,500 connectors assembled during the period, (2) conducting engineering evaluation of connector performance at 18.2 Nm torque, (3) implementing enhanced testing with statistical sampling per MIL-STD-414, and (4) removing the tool from service. The response acknowledges the measurement uncertainty issue and includes proper FDA regulatory considerations under 21 CFR 820.90 for product impact assessment.

**corrective_action:** The corrective actions address the systemic root cause identified in the 5 Whys analysis. The response implements: (1) risk-based calibration program considering usage frequency and application criticality, (2) interim verification protocol with weekly checks for high-usage tools, (3) usage tracking system to correlate with drift patterns, and (4) training updates. These actions directly address the systemic calibration interval methodology issue rather than just fixing the individual wrench. The interim verification specifically addresses the detection gap between calibration cycles.

---

### QNC-005: Interpreting basic cost of quality data for management presentation

**Difficulty:** easy | **Category:** cost-of-quality | **Score:** 100.0%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| data_interpretation | 0.35 | pass | 1.0 |
| investment_recommendation | 0.35 | pass | 1.0 |
| communication_quality | 0.3 | pass | 1.0 |

**data_interpretation:** The response correctly calculates total COQ at $652K (5.26% of revenue) and explicitly identifies this as 'Above industry benchmark of 3-4%'. It accurately identifies the prevention-failure imbalance: 'Prevention costs represent only 9.5% of total CoQ - Well below optimal 50-60%' and 'Internal failures dominate at 47.5% of CoQ - Indicating poor upstream control'. The analysis demonstrates understanding of quality economics principles by noting prevention should be 50-60% of CoQ rather than the actual 9.5%.

**investment_recommendation:** The response recommends a specific $150K prevention investment split between process validation ($90K) and supplier qualification ($60K), directly targeting the largest failure sources. It provides specific ROI justification with 'Conservative 30% reduction in internal failures = $93K annual savings' and breaks this down by category (scrap reduction: $43K, rework: $30K, delays: $20K). The 18-month payback period calculation demonstrates proper financial analysis for management.

**communication_quality:** The response is structured for executive consumption with clear sections, a table format for cost structure, and leads with the business impact ('Total CoQ: $652K (5.26% of revenue)'). It translates quality metrics into financial terms throughout and provides specific, actionable recommendations with measurable success metrics. The language is professional and business-focused rather than technical quality jargon.

---

### QNC-006: Basic CAPA initiation for a recurring defect

**Difficulty:** easy | **Category:** capa-management | **Score:** 100.0%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| capa_decision | 0.25 | pass | 1.0 |
| problem_statement | 0.25 | pass | 1.0 |
| team_and_methodology | 0.25 | pass | 1.0 |
| initial_investigation_direction | 0.25 | pass | 1.0 |

**capa_decision:** The agent correctly identifies that a CAPA is required and provides multiple valid justification criteria: recurring nonconformity (3 NCRs in 60 days), multiple production lots affected indicating systemic issue, cross-equipment occurrence, quality-critical application affecting seal performance, and significant financial impact ($8,200). The reasoning demonstrates understanding that individual NCR dispositions addressed symptoms but not the underlying systemic cause.

**problem_statement:** The problem statement is specific and data-driven, including: specific part number (5520-C), quantitative data (Ra 1.8-2.4µm vs 1.6µm spec), timeframe (60 days), scope (multiple machines CNC-T04, CNC-T06, multiple operators), financial impact ($8,200), and business context (hydraulic seal performance). It clearly articulates this as a systemic process issue rather than isolated events.

**team_and_methodology:** The team composition is appropriately cross-functional including Quality Engineer (lead), Manufacturing Engineer for process expertise, CNC Setup Technician for machine/tooling knowledge, Quality Technician for measurement, and Production Supervisor for operations perspective. The 8D methodology selection is well-justified for recurring manufacturing defects with structured team-based approach, and includes specific implementation plan with fishbone diagram and 5-Why analysis as primary tools.

**initial_investigation_direction:** The agent identifies key investigation areas that leverage the multi-machine, multi-operator pattern: cutting tool condition/specification, machine parameters (speeds, feeds, coolant), raw material variation, measurement system analysis, and environmental factors. The D4 root cause analysis section specifically outlines these investigation areas, demonstrating understanding that the cross-machine pattern rules out single-machine causes and points toward material, tooling, or method factors.

---

### QNC-007: Determining correct AQL sampling plan for mixed criticality lot

**Difficulty:** easy | **Category:** incoming-inspection | **Score:** 47.5%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| sample_size_determination | 0.4 | fail | 0.0 |
| rationale_for_aql_levels | 0.35 | pass | 1.0 |
| practical_considerations | 0.25 | partial | 0.5 |

**sample_size_determination:** The agent correctly determined lot size 1,200 at Level II gives code letter K and sample size 125. However, the accept/reject numbers are incorrect. For AQL 0: correctly states Ac=0, Re=1. For AQL 1.0: incorrectly states Ac=3, Re=4 (should be Ac=7, Re=8). For AQL 4.0: incorrectly states Ac=10, Re=11 (should be Ac=18, Re=19). The agent did recognize that the same sample of 125 can be used for all characteristics, but the fundamental accept/reject number errors for major and minor characteristics make this a fail.

**rationale_for_aql_levels:** The agent correctly explains the rationale: AQL 0 for critical because 'Patient safety is paramount - incorrect bore could cause blade detachment during surgery' with zero tolerance. AQL 1.0 for major because dimensional defects affect functionality and 'Could disrupt surgical workflow' but are not immediately life-threatening. AQL 4.0 for minor because 'Surface finish doesn't affect safety or primary function' and 'Some cosmetic variation acceptable.' Also notes regulatory requirement under FDA 21 CFR 820 for critical safety features and uses risk-based approach.

**practical_considerations:** The agent mentions some practical considerations including 'Medical device regulations justify the conservative AQL structure' and references FDA 21 CFR 820, but fails to address key practical elements from the pass criteria: (1) does not mention that critical bore dimension may warrant variable data collection for SPC, (2) does not mention data retention requirements per 21 CFR 820.80 with actual measurement values, (3) does not explicitly state that qualified supplier status does not reduce AQL for critical dimensions - critical is always AQL 0 regardless of supplier history.

---

### QNC-008: Supplier SCAR response evaluation — weak root cause

**Difficulty:** easy | **Category:** supplier-quality | **Score:** 100.0%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| root_cause_evaluation | 0.4 | pass | 1.0 |
| corrective_action_evaluation | 0.35 | pass | 1.0 |
| feedback_specificity | 0.25 | pass | 1.0 |

**root_cause_evaluation:** The agent correctly identifies that 'operator failed to check parts during production run' is superficial and inadequate. Specifically states the root cause 'stops at human error without deeper investigation' and identifies the critical gap: 'Why didn't the operator check parts?' The agent correctly distinguishes between the cause of the defect (missing analysis of process capability, tooling wear, setup verification) and the escape (system failures ignored). Demonstrates understanding that the supplier failed to analyze why the parts were out of tolerance in the first place versus why they weren't detected.

**corrective_action_evaluation:** The agent correctly identifies that retraining is insufficient, noting it 'does not address systemic issues and violates the principle of addressing root causes rather than symptoms.' Recognizes the narrow scope issue and explicitly calls for 'process improvements' and 'error-proofing measures.' Correctly identifies that the 100% inspection for 3 lots is 'detection-focused rather than prevention-focused' and distinguishes this as containment rather than true corrective action. Recommends higher-rank corrective actions including SPC implementation and process control improvements.

**feedback_specificity:** Provides specific, actionable feedback with clear structure. Explicitly states 'Reject current response and request complete rework within 30 days.' Specifies exactly what the supplier must provide: proper 5-Why or fishbone analysis, expanded corrective actions including SPC and poka-yoke measures, and improved effectiveness verification with statistical evidence (Cpk data). References specific IATF 16949 Section 10.2.1.1 requirements and notes compliance implications. Sets clear expectations and timeline for resubmission.

---

### QNC-009: MRB disposition on use-as-is with engineering justification in aerospace

**Difficulty:** medium | **Category:** ncr-disposition | **Score:** 67.5%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| disposition_decision | 0.25 | pass | 1.0 |
| engineering_justification | 0.3 | pass | 1.0 |
| customer_approval_process | 0.25 | partial | 0.5 |
| process_improvement | 0.2 | fail | 0.0 |

**disposition_decision:** The agent correctly identifies USE-AS-IS as the appropriate disposition. While the parts are technically within tolerance (2.91mm > 2.90mm LSL), the agent appropriately treats this as requiring MRB review due to the marginal measurements. The response includes proper engineering analysis noting the FEA minimum of 2.75mm provides substantial safety margin (0.16mm above minimum requirement). The disposition is technically sound and operationally appropriate.

**engineering_justification:** The response provides comprehensive engineering justification: (1) confirms all parts are within drawing tolerance with detailed conformance analysis, (2) references FEA validation showing parts exceed minimum structural requirement by 5.8% with 2.75mm minimum vs 2.91mm minimum measured, (3) identifies the feature as non-load-bearing stiffener rib, (4) includes statistical analysis of measurements, and (5) provides risk assessment showing LOW technical risk. The justification is structured, data-driven, and addresses form, fit, and function.

**customer_approval_process:** The response includes a detailed customer approval process with Boeing notification package and required approvals. However, there's a technical error: since all parts are within tolerance (2.91mm > 2.90mm LSL), AS9100 §8.7.1 customer approval for use-as-is is not technically required - this applies only to nonconforming product. The agent should have noted this distinction while still recommending proactive Boeing notification due to marginal results and critical path timing. The process outlined is thorough but based on incorrect regulatory interpretation.

**process_improvement:** The response lacks any process improvement recommendations. While it mentions 'Corrective action analysis for future prevention' in the AS9100D checklist, there is no actual investigation into why the process is running near the lower specification limit (mean 2.924mm vs 3.00mm nominal). No recommendations for checking tool compensation, fixture setup, raw material dimensions, or implementing SPC monitoring. The response accepts the marginal results without addressing the underlying process centering issue.

---

### QNC-010: SPC capability study shows capable but off-center process

**Difficulty:** medium | **Category:** spc-interpretation | **Score:** 100.0%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| capability_calculations | 0.3 | pass | 1.0 |
| interpretation | 0.35 | pass | 1.0 |
| corrective_action | 0.35 | pass | 1.0 |

**capability_calculations:** The agent correctly calculates all four capability indices with proper formulas and accurate arithmetic: Cp = 1.79, Cpk = 0.83, Pp = 1.56, Ppk = 0.73. The calculations show proper understanding of using σ_within for Cp/Cpk and σ_overall for Pp/Ppk. The agent correctly identifies that Ppk = 0.73 does not meet the customer requirement of ≥ 1.67, showing clear understanding of which metric the customer is evaluating.

**interpretation:** The agent correctly interprets the capability indices, identifying two critical issues: (1) a centering problem where the process mean (45.08mm) is shifted +0.08mm from nominal, consuming 53% of the tolerance band, and (2) between-subgroup variation indicated by σ_overall > σ_within. The agent properly distinguishes that Cp = 1.79 shows potential capability while Cpk = 0.83 reveals the centering issue. The analysis correctly identifies centering as the primary problem, not variation.

**corrective_action:** The agent recommends the correct sequence of actions: (1) adjust tooling/setup to shift mean from 45.08mm to 45.00mm (recognizing this as a centering fix), (2) investigate process stability to address between-subgroup variation, (3) conduct a new capability study after corrections, and (4) demonstrates understanding that even after centering, additional variation reduction may be needed to achieve Ppk ≥ 1.67. The response shows proper understanding of IATF 16949 requirements and PPAP process, recommending resubmission only after corrections are verified.

---

### QNC-011: Writing an 8D report for an automotive customer complaint

**Difficulty:** medium | **Category:** root-cause-analysis | **Score:** 77.5%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| d2_problem_definition | 0.2 | partial | 0.5 |
| d3_containment | 0.25 | partial | 0.5 |
| root_cause_hypothesis | 0.3 | pass | 1.0 |
| d5_d7_corrective_preventive | 0.25 | pass | 1.0 |

**d2_problem_definition:** The response provides a structured problem definition with What/Where/When/How Much details and identifies the 2.4% failure rate and measurement discrepancy. However, it does not use proper IS/IS NOT analysis format and fails to highlight the measurement system discrepancy as the key analytical clue. The response mentions the discrepancy but doesn't emphasize it as the critical data point that should drive the investigation direction.

**d3_containment:** The response addresses internal containment well (quarantine inventory, 100% inspection, stop shipments) and mentions coordination with Continental AG. However, it fails to specifically address the critical containment issue of the remaining 488 uninspected parts at Continental's facility. The response mentions 'coordinate measurement comparison' but doesn't explicitly offer to sort the remaining parts at Continental using their CMM at your cost, which is the most immediate containment need.

**root_cause_hypothesis:** The response correctly identifies 'Measurement System Discrepancy' as the most likely root cause, supported by solid evidence analysis: 0 rejects internally vs. 2.4% at customer, consistent customer values near tolerance limit, and systematic rather than random variation. It properly lists contributing factors including fixture/clamping differences, datum reference frame setup, and GD&T interpretation variations. The response demonstrates understanding that this is likely a measurement issue rather than a process issue.

**d5_d7_corrective_preventive:** D5 corrective actions are appropriately focused on measurement system correlation study, enhanced inspection protocols, and process capability assessment. D7 prevention includes systematic improvements like quarterly correlation studies with customers, MSA implementation, and standardized CMM procedures. The actions are logically connected to the identified root cause of measurement system discrepancy and include both immediate fixes and long-term prevention strategies.

---

### QNC-012: Supplier audit finding — inadequate calibration program

**Difficulty:** medium | **Category:** supplier-quality | **Score:** 100.0%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| finding_identification | 0.3 | pass | 1.0 |
| audit_recommendation | 0.25 | pass | 1.0 |
| corrective_action_expectations | 0.25 | pass | 1.0 |
| product_risk_assessment | 0.2 | pass | 1.0 |

**finding_identification:** The response correctly identifies three distinct findings with appropriate severity classifications: (1) MAJOR for overdue calibrations (8.2% of gauges overdue) with correct AS9100D §7.1.5.1(a) reference, (2) MAJOR for inadequate out-of-tolerance investigation with correct AS9100D §7.1.5.1(b) reference citing the specific requirement for impact assessment, and (3) MINOR for inadequate calibration interval determination. The severity classifications are accurate - the missing impact assessment is correctly identified as MAJOR rather than minor, and the universal intervals are appropriately classified as MINOR.

**audit_recommendation:** The response provides 'CONDITIONAL APPROVAL WITH IMMEDIATE ACTION REQUIRED' which appropriately allows corrective action opportunity while imposing conditions. It includes STOP WORK requirement until major findings are addressed, requires corrective action plan with specific timelines (15-60 days), and establishes follow-up audit within 45 days. The response appropriately recognizes the severity of findings while providing a proportionate response that allows the supplier to correct rather than immediate disqualification.

**corrective_action_expectations:** The response specifies detailed corrective action expectations including: (1) immediate containment - calibrate all 28 overdue instruments within 48 hours, (2) retrospective impact assessment for the out-of-tolerance micrometer identifying all affected products, (3) systemic corrections including automated alert systems and formal out-of-tolerance investigation procedures, (4) risk-based calibration interval analysis, and (5) clear timelines (15-60 days) and verification requirements. The response distinguishes between immediate corrections and systemic improvements.

**product_risk_assessment:** The response clearly identifies product risk, stating that measurements on 'flight-critical components may be invalid, compromising product conformity verification' and noting 'potential release of non-conforming safety-critical parts.' It requires immediate impact assessment to 'identify and quarantine all products measured since last valid calibration' and mandates customer notification within 24 hours regarding potential impact to delivered products. The response connects calibration findings directly to product conformance uncertainty.

---

### QNC-013: CAPA effectiveness verification — determining monitoring period adequacy

**Difficulty:** medium | **Category:** capa-management | **Score:** 100.0%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| statistical_assessment | 0.35 | pass | 1.0 |
| risk_based_decision | 0.35 | pass | 1.0 |
| additional_evidence | 0.3 | pass | 1.0 |

**statistical_assessment:** The response demonstrates strong statistical reasoning by calculating that with an original 0.4% defect rate, ~5 defects would be expected in 1,200 units. It correctly identifies that observing zero defects provides insufficient statistical confidence, states the 95% confidence interval upper bound is ~0.31%, and recommends targeting 2,400-3,000 units to achieve 95% confidence that defect rate ≤ 0.1%. The response explicitly addresses the relationship between sample size, original defect rate, and confidence level rather than applying simple 'no defects = fixed' logic.

**risk_based_decision:** The response clearly recommends extending the monitoring period specifically because this is a Class III implantable device. It provides detailed risk rationale including the life-sustaining nature, potential for device malfunction leading to revision surgery, and patient morbidity/mortality risks. The response emphasizes that 'the quality manager should prioritize patient safety over administrative closure timelines' and recommends minimum 6 months total monitoring with 2,400+ units, demonstrating appropriate risk adjustment for the device classification.

**additional_evidence:** The response recommends comprehensive supplementary evidence including: daily thermal profile verification logs, weekly SPC trending of reflow parameters, monthly destructive solder joint inspection audits, quarterly process capability studies (Cpk analysis), destructive pull-strength testing, formal reflow process validation study, and supplier verification of solder paste handling. It specifically calls for process capability study showing Cpk ≥ 1.33 and validation protocol confirming sustained process control, going well beyond relying solely on defect counts.

---

### QNC-014: Regulatory audit preparation — CAPA system review

**Difficulty:** medium | **Category:** regulatory-compliance | **Score:** 100.0%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| gap_assessment | 0.3 | pass | 1.0 |
| pre_inspection_actions | 0.4 | pass | 1.0 |
| inspection_strategy | 0.3 | pass | 1.0 |

**gap_assessment:** The response correctly identifies all three specific gaps against prior commitments: (1) 6 overdue CAPAs with the 2-month overdue CAPA specifically flagged as 'HIGH RISK' for contradicting the 180-day commitment, (2) 82% effectiveness verification leaving an 18% gap against the 'mandatory' commitment, and (3) 4 missed monthly management reviews over 2 years showing inconsistent implementation. The response explicitly states these contradict the commitments rather than just presenting improvements.

**pre_inspection_actions:** The response recommends appropriate pre-inspection actions: (1) Prioritizes the 2-month overdue CAPA for closure or documented justification, addresses all 6 overdue CAPAs with revised timelines and rationale rather than rushed closures, (2) Completes effectiveness verification for the missing 18% of CAPAs, (3) Documents the 4 missed management reviews with explanations, and (4) Prepares trend analysis and evidence compilation. The 3-week timeline is realistic and focuses on documentation quality over hasty closure.

**inspection_strategy:** The response advises a transparent, data-driven approach: (1) Proactively presents improvement metrics (83-day reduction in closure time, doubled effectiveness verification rate), (2) Recommends honest acknowledgment of remaining gaps with the specific language 'We recognize 6 overdue CAPAs represent continued opportunity for improvement', (3) Emphasizes the improvement trajectory and sustainability measures, and (4) Includes mock inspection preparation and briefing the inspection team on both improvements and challenges.

---

### QNC-015: Control chart selection for a new process characteristic

**Difficulty:** medium | **Category:** spc-interpretation | **Score:** 85.0%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| chart_selection | 0.4 | pass | 1.0 |
| minimum_data_requirements | 0.3 | pass | 1.0 |
| practical_guidance | 0.3 | partial | 0.5 |

**chart_selection:** The response correctly identifies all three chart types: (1) I-MR chart for critical diameter because n=1 (individual measurements), explicitly stating 'X-bar/R charts are inappropriate since you cannot calculate meaningful subgroup averages or ranges', (2) c-chart for solder joint defects because it's count data with fixed opportunity area (847 joints per board), clearly explaining 'X-bar/R charts are completely inappropriate for count data', and (3) p-chart for leak test because it's attribute data (pass/fail) with variable sample sizes. The response provides clear rationale for why X-bar/R is wrong for each characteristic and demonstrates understanding of the fundamental differences between continuous, count, and attribute data types.

**minimum_data_requirements:** The response specifies appropriate minimum data requirements for each chart type: I-MR chart requires 'Minimum: 20-25 individual measurements' with recommendation for 100+ measurements for robust limits; c-chart requires 'Minimum: 20-25 boards (subgroups)' with recommendation for 200-250 boards; p-chart requires 'Minimum: 20-25 subgroups (shifts) with at least 1,000 total units inspected' and notes the statistical validity requirement that 'np̄ ≥ 5 and n(1-p̄) ≥ 5'. These requirements align with standard SPC practice of 20-25+ subgroups for initial control limit establishment.

**practical_guidance:** The response provides some practical guidance including data collection sequence requirements ('measurements are taken in time order'), consistent inspection criteria for defect counting, and statistical validity checks for the p-chart (np̄ ≥ 5 requirement). However, it misses key practical considerations: does not mention normality assumption verification for I-MR charts, does not discuss Poisson distribution assumption for c-charts, and does not address the low defect rate sensitivity issue that could affect p-chart effectiveness for leak testing where defect rates might be very low.

---

### QNC-016: Customer-reported field failure with no internal detection history

**Difficulty:** hard | **Category:** ncr-disposition | **Score:** 87.5%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| immediate_actions_and_containment | 0.25 | partial | 0.5 |
| mdr_assessment | 0.25 | pass | 1.0 |
| investigation_plan | 0.3 | pass | 1.0 |
| customer_management | 0.2 | pass | 1.0 |

**immediate_actions_and_containment:** The response includes quarantining the three affected lots but fails to place a quality hold on ALL biopsy forceps in finished goods inventory for assessment. While it mentions 'quarantine remaining inventory from the three affected lots,' it doesn't address the broader containment needed given that this could be a design or process issue affecting multiple lots. The response correctly avoids immediate full recall but misses the comprehensive inventory hold that would be appropriate for a multi-lot failure pattern.

**mdr_assessment:** Correctly identifies MDR reporting is required within 30 days under 21 CFR 803.50, recognizing that device malfunction requiring medical intervention (endoscopic retrieval) could reasonably result in death or serious injury. Properly notes the extended procedure time with additional anesthesia poses patient risk, and mentions coordinating with international regulatory requirements. The assessment accurately captures the regulatory obligation.

**investigation_plan:** Develops a comprehensive investigation with appropriate phases: fractographic analysis and SEM examination for crack initiation sites, material composition verification, manufacturing records review for affected lots, re-evaluation of loading conditions beyond uniaxial tension considering multi-axial stresses during tissue sampling, and finite element analysis. Correctly recognizes the need to assess the gap between design verification conditions and actual clinical use, and includes material property testing and microstructural analysis. The multi-lot pattern is appropriately addressed through process and design analysis.

**customer_management:** Demonstrates appropriate customer relationship management: acknowledges the issue and expresses concern for patient impact, commits to comprehensive investigation with timeline, provides regular updates on investigation progress, and takes a transparency approach. Includes executive engagement, technical support, and considers temporary product replacement program. The response avoids defensive posturing and recognizes the clinical seriousness of endoscopic retrieval procedures, providing specific timelines (preliminary findings in 7 days, root cause in 21 days).

---

### QNC-017: Supplier audit reveals falsified Certificates of Conformance

**Difficulty:** hard | **Category:** supplier-quality | **Score:** 90.0%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| containment_scope | 0.3 | pass | 1.0 |
| notification_and_escalation | 0.25 | pass | 1.0 |
| disposition_methodology | 0.25 | pass | 1.0 |
| supplier_decision | 0.2 | partial | 0.5 |

**containment_scope:** Response correctly identifies comprehensive containment scope: (1) all castings received in past 5 months (20,000 parts), (2) all WIP containing these castings with red-tagging, (3) all finished goods with suspect parts, (4) shipped products requiring customer notification, and (5) creates traceability matrix linking casting lots to final products. Recognizes safety-critical nature of brake components and notes potential catastrophic failure risk. Includes proper stop-ship and production halt orders.

**notification_and_escalation:** Response identifies all required notifications: (1) internal escalation to CEO, CTO, Quality VP and Legal within 24 hours, (2) immediate OEM customer notification with preliminary risk assessment, (3) regulatory bodies including NHTSA for US market, (4) IATF certification body notification of major non-conformance. Correctly recognizes this as systematic deception requiring different treatment than standard supplier quality issues.

**disposition_methodology:** Response outlines proper disposition methodology: (1) 100% incoming inspection with full tensile testing for raw castings using statistical sampling per ANSI/ASQ Z1.4 with AQL 0.25 for critical defects, (2) destructive testing program for WIP/finished goods with minimum 30 pieces per production lot, (3) customer notification for shipped products with field action consideration, (4) involves independent testing rather than immediate scrapping or blind acceptance. Recognizes need to test actual material properties since falsification doesn't necessarily mean material is bad.

**supplier_decision:** Response recommends 'CONTROLLED RE-QUALIFICATION' which is problematic for a data falsification case. While it includes good elements like quality manager replacement, enhanced oversight, and financial accountability, it fails to recognize that falsified data is a trust-destroying integrity issue that warrants immediate phase-out per quality engineering best practices. The recommendation to maintain relationship with enhanced controls treats this as a capability issue rather than an integrity breach. Does initiate alternative sourcing but as backup rather than primary replacement strategy.

---

### QNC-018: SPC in-control but customer assembly complaints increasing

**Difficulty:** hard | **Category:** spc-interpretation | **Score:** 100.0%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| tolerance_stackup_analysis | 0.35 | pass | 1.0 |
| root_cause_diagnosis | 0.3 | pass | 1.0 |
| resolution_recommendation | 0.35 | pass | 1.0 |

**tolerance_stackup_analysis:** The response performs a comprehensive tolerance stack-up analysis. It correctly calculates the assembly clearance as Bore ID - Shaft OD, determines the mean clearance as 12.018 - 12.002 = 0.016mm, calculates the combined standard deviation using RSS method as √(0.0046² + 0.0018²) = 0.0050mm, and determines the probability of interference using Z-score calculation (Z = -3.2, P ≈ 0.07% or 700 ppm). The analysis correctly identifies that interference occurs when clearance < 0 and explains how this statistical interference rate aligns with the observed 0.3% complaint rate.

**root_cause_diagnosis:** The response correctly identifies that both processes are individually capable and in control, so the root cause is not a manufacturing defect but rather a tolerance stack-up interaction. It specifically diagnoses that 'your shaft process is running too close to the upper specification limit while the customer's bore runs near the lower end of their tolerance band,' creating a systematic bias toward interference fits. The response recognizes this as a specification adequacy issue rather than blaming either party's manufacturing process.

**resolution_recommendation:** The response recommends a collaborative approach with specific actions: (1) adjust the process mean from 12.002mm to 11.995mm to eliminate statistical interference while maintaining Cpk > 1.33, (2) tighten process control with new control limits and increased sampling frequency, (3) validate the solution with assembly clearance verification showing zero statistical interference, and (4) propose customer collaboration including centering their bore process at true center and establishing shared measurement standards. The recommendation is technically sound and maintains the partnership relationship.

---

### QNC-019: Non-conformance discovered on already-shipped product — measurement system failure

**Difficulty:** hard | **Category:** ncr-disposition | **Score:** 72.5%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| risk_quantification | 0.3 | partial | 0.5 |
| containment_strategy | 0.25 | partial | 0.5 |
| customer_notification | 0.25 | pass | 1.0 |
| corrective_action | 0.2 | pass | 1.0 |

**risk_quantification:** The response correctly identifies that the 0.018mm bias means the probe reads shallow and actual parts are deeper than measured. It correctly calculates that the effective acceptance range was 4.488-4.548mm due to the bias. However, it provides only a rough statistical estimate (15-25% potentially above USL) without actually reviewing the original measurement data from the 14 lots to determine which specific lots had measurements in the upper tolerance band that would push them out of spec with the bias correction. The quantification is directionally correct but lacks the data-driven lot-level analysis required for proper risk stratification.

**containment_strategy:** The response implements appropriate immediate containment (quarantine 5 remaining lots, stop shipments, remove probe from service) and requests customer inventory holds. However, it does not stratify containment by risk level based on the original measurement data. It treats all shipped lots similarly rather than identifying which lots had measurements in the upper 1/3 of tolerance (highest risk) versus lower measurements (lower risk). The strategy is sound but lacks the data-driven risk stratification that would optimize containment efforts and reduce unnecessary customer disruption.

**customer_notification:** The response provides excellent customer notification approach with proactive 24-hour timeline, includes specific lot numbers and quantities, explains the measurement bias direction and functional impact (blade retention force), provides clear quarantine instructions, and establishes emergency contacts. The follow-up communication plan at 48-72 hours includes detailed risk assessment and recommended actions. The response demonstrates transparency and acknowledges the importance of maintaining customer relationships during the crisis. It appropriately frames this as a patient safety concern requiring immediate action.

**corrective_action:** The response addresses both immediate and systemic causes effectively. Immediate actions include root cause analysis of why the probe qualification warning was dismissed and re-qualification of all CMM probes. The corrective action appropriately identifies the software configuration issue and implements mandatory stops for probe qualification failures (engineering control) rather than relying solely on operator training. The long-term actions include measurement system improvements with automated monitoring, quality system enhancements to eliminate operator override capability, and comprehensive training programs. The response also includes preventive measures like quarterly Gage R&R studies and probe monitoring.

---

### QNC-020: Multiple interacting root causes for injection molding defect

**Difficulty:** hard | **Category:** root-cause-analysis | **Score:** 82.5%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| rca_critique | 0.2 | pass | 1.0 |
| interacting_causes | 0.35 | partial | 0.5 |
| investigation_design | 0.25 | pass | 1.0 |
| corrective_actions | 0.2 | pass | 1.0 |

**rca_critique:** The agent correctly identifies all key flaws: (1) single-cause fallacy despite multiple interacting issues, (2) ignored cavity-specific patterns, (3) contradictory logic noting 'low injection pressure cannot simultaneously cause both incomplete fill AND excessive material flow (flash)', (4) failed corrective action proved root cause wrong, and (5) 5 Whys was wrong tool for multi-cavity, multi-defect problem. Specifically calls out that the recommendation 'actually worsened the cavity imbalance' showing poor understanding of mold flow dynamics.

**interacting_causes:** Agent identifies multiple interacting causes including tool degradation from continuous operation, mold flow imbalance (gate wear, venting blockage, cooling circuit issues), material property drift from resin lot change, and process parameter drift. However, misses the specific clamp force distribution issue that would explain the cavity pattern (1&4 vs 2&3) and doesn't connect the physical evidence to pressure-indicating film testing or tie bar stretch from 24/7 operation. The causes identified are reasonable but less precise than the rubric's mechanical explanation.

**investigation_design:** Provides systematic, prioritized investigation approach: Phase 1 focuses on tool condition assessment (gate inspection, venting, cooling circuits, mold alignment), Phase 2 on material verification (resin lot comparison, rheological testing), Phase 3 on process analysis (cavity-by-cavity fill study, pressure monitoring), and Phase 4 on mold flow simulation. The sequence is logical (tool condition first, then material, then process) and includes specific actions like 'measure gate land length', 'GPM measurement per circuit', and 'cavity pressure monitoring if sensors available'.

**corrective_actions:** Comprehensive multi-pronged corrective actions addressing all contributing causes: immediate tool maintenance (clean vents, flush cooling, gate refurbishment), process revalidation, cavity-specific monitoring implementation, updated PM schedule for continuous operation, material lot qualification, and long-term predictive maintenance program. Each identified cause gets specific corrective action, and the agent correctly notes the need to 'stop production' and 'quarantine suspect parts' for medical device compliance.

---

### QNC-021: Intermittent BGA solder defect that cannot be reproduced in testing

**Difficulty:** hard | **Category:** root-cause-analysis | **Score:** 100.0%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| diagnosis_of_detection_gap | 0.35 | pass | 1.0 |
| investigation_methodology | 0.35 | pass | 1.0 |
| process_improvement_recommendations | 0.3 | pass | 1.0 |

**diagnosis_of_detection_gap:** The response correctly explains the 2D X-ray limitation: 'provides a superimposed view of the entire solder joint volume' where 'small, distributed voids throughout the joint volume appear as acceptable <12% voiding in 2D projection' while 'voids concentrated at the die-side interface...are masked by good solder in other joint regions.' It identifies that thermal cycling fails because it doesn't replicate 'combined thermal + mechanical + vibrational stresses of field use' and lacks 'long-term creep effects' that occur over months/years. The response understands that corner positions (A1-C3) are critical stress concentration areas where interface voids become problematic.

**investigation_methodology:** The response proposes a comprehensive multi-phase investigation including: (1) '3D X-ray CT Analysis' to 'map void distribution in 3D space' and 'quantify void concentration specifically at die-side interface', (2) 'Acoustic Microscopy (SAM)' to detect delamination, (3) expanded cross-sectional analysis of production boards, (4) 'Reflow Profile Analysis' to 'map actual temperature distribution across board during reflow', (5) component-level analysis including solder paste characterization and board warpage measurement, and (6) 'Combined Environmental Testing' with thermal cycling plus vibration and extended duration testing to better simulate field conditions.

**process_improvement_recommendations:** The response provides specific, technically sound process improvements: (1) reflow optimization with 'zone-specific heating control', extended preheat duration, and reduced heating rates, (2) nitrogen atmosphere implementation, (3) solder paste modifications including smaller particle size and aperture optimization for corner balls, (4) implementation of '3D X-ray Implementation' with revised acceptance criteria limiting 'interface voiding to <15% while allowing bulk voiding up to 25%', and (5) statistical process control with 'control charts for die-side interface void density' and corner-ball-specific monitoring. The recommendations address the specific interface voiding mechanism and differentiate between whole-joint and interface-layer criteria.

---

### QNC-022: Sole-source titanium forging supplier with recurring quality issues

**Difficulty:** hard | **Category:** supplier-quality | **Score:** 100.0%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| supplier_development_approach | 0.3 | pass | 1.0 |
| dual_source_strategy | 0.25 | pass | 1.0 |
| production_continuity | 0.25 | pass | 1.0 |
| airbus_response | 0.2 | pass | 1.0 |

**supplier_development_approach:** The response demonstrates collaborative supplier development approach: deploys resident quality engineer at supplier for 90 days, conducts joint failure mode analysis focusing on die design optimization and forging parameters, implements SPC for critical parameters, and establishes upgraded quality agreement with shared investment model (supplier-funded buffer inventory). Shows understanding of metallurgical factors affecting grain flow (temperature profiles, press tonnage, forming speed) rather than purely punitive escalation.

**dual_source_strategy:** Response immediately begins alternate source qualification as parallel path, not threat. Identifies specific qualified candidates (Wyman-Gordon, Arconic, ATI), provides realistic timeline (21 months), estimates investment ($1.3M including $800K tooling), and frames dual-sourcing as supply chain risk mitigation. Explicitly plans to brief Airbus on dual-source initiative as positive risk management. Includes staggered qualification approach to maintain leverage with current supplier.

**production_continuity:** Addresses 21-month dependency period comprehensively: establishes 10-unit safety stock buffer, implements 100% ultrasonic and metallographic inspection for individual forging assessment, creates expedited replacement protocol (2-month emergency lead time), and establishes joint contingency plan with Airbus. Plans monthly progress reviews and quarterly supply chain risk assessments to maintain transparency during transition period.

**airbus_response:** Provides structured, transparent Airbus communication strategy: acknowledges quality concerns and sole-source risk in Week 1 executive summary, commits to monthly progress reviews with detailed metrics dashboard, establishes quarterly supplier development updates, and includes Airbus in supplier selection process. Presents comprehensive 3-phase strategy with specific milestones and timeline, demonstrating proactive customer relationship management.

---

### QNC-023: FDA 483 observation response for CAPA system deficiency

**Difficulty:** hard | **Category:** regulatory-compliance | **Score:** 100.0%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| obs1_response_quality | 0.3 | pass | 1.0 |
| obs2_response_quality | 0.3 | pass | 1.0 |
| obs3_response_quality | 0.25 | pass | 1.0 |
| overall_response_quality | 0.15 | pass | 1.0 |

**obs1_response_quality:** The response addresses all required elements: (1) acknowledges incomplete effectiveness verification documentation, (2) identifies root cause as procedural gap in QP-0820-100 lacking effectiveness verification methodology, (3) provides immediate action with retroactive effectiveness verification for all 5 cited CAPAs with specific completion dates and evidence (process data, compliance rates, quality metrics), (4) implements systemic corrective action by revising procedure to Rev G with mandatory effectiveness verification requirements and specific criteria, (5) performs scope extension by reviewing all open CAPAs (n=18) and identifying 3 additional cases requiring retroactive verification. Includes specific timelines and evidence documentation.

**obs2_response_quality:** The response comprehensively addresses the observation: (1) acknowledges unacceptable delay for surgical device malfunction complaint, (2) investigates delay causes (process breakdown, communication gap, risk assessment failure, resource constraints), (3) implements corrective action with mandatory timelines (safety-related complaints: 5 business days, quality-related: 10 business days), (4) establishes process changes including automated alerts and escalation matrix, (5) addresses underlying MDR concerns by noting 'notified affected customers and regulatory bodies as appropriate' and implementing enhanced triage for surgical device complaints. Includes system automation and resource allocation measures.

**obs3_response_quality:** The response fully addresses the observation: (1) acknowledges procedural deficiency in QP-0820-100 lacking specific CAPA initiation criteria, (2) implements corrective action by revising procedure to include explicit mandatory triggers (safety-related complaints, device malfunctions, regulatory feedback, audit findings, process capability degradation, recurring nonconformances), (3) establishes documented decision record requirement for CAPA initiation decisions with decision matrix tool, (4) performs retrospective review by examining all 2024 complaints/nonconformances closed without CAPA, identifying 8 records requiring retrospective CAPAs, and implementing CAPA Review Board governance.

**overall_response_quality:** The response demonstrates excellent systemic thinking by treating the three observations as interconnected CAPA system maturity issues. Each observation receives specific acknowledgment, root cause analysis, immediate and systemic corrective actions, scope extension, and specific timelines with responsible parties. The tone is appropriately accountable and professional without being defensive. Includes comprehensive systemic improvements (management commitment, technology investments, performance metrics) and supporting documentation. Shows understanding that the observations collectively indicate broader CAPA system deficiencies requiring enterprise-level response.

---

### QNC-024: Building the cost of quality business case for automation investment

**Difficulty:** medium | **Category:** cost-of-quality | **Score:** 67.5%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| coq_analysis | 0.25 | pass | 1.0 |
| roi_calculation | 0.35 | partial | 0.5 |
| business_presentation | 0.25 | pass | 1.0 |
| broader_coq_strategy | 0.15 | fail | 0.0 |

**coq_analysis:** Correctly calculates total COQ as $2.7M (5.6% of revenue vs. 2-4% benchmark). Identifies the unhealthy distribution with prevention only 6.8% of total COQ and failure costs representing the majority. Specifically highlights that Cell 7 accounts for $310K of total scrap (23% of total internal failures), demonstrating understanding of the disproportionate impact of this single operation.

**roi_calculation:** Provides detailed financial analysis with $325K investment and $470,750 annual savings, showing 8.2 month payback and 45% Year 1 ROI. However, the benefits appear over-estimated - claims 85% scrap reduction yielding $263,500 savings from $310K base, which would require near-perfect defect elimination. The Cpk improvement from 1.05 to 1.67 is significant but may not achieve 85% scrap reduction in practice. Secondary benefits calculations lack detailed justification.

**business_presentation:** Excellent plant manager presentation: leads with clear executive summary showing $325K investment, $478K annual savings, 8.2 month payback. Uses business language focusing on dollars rather than quality metrics. Addresses implementation risks and mitigation strategies. Concludes with compelling call to action emphasizing the monthly cost of delay ($39K) and safety component risk exposure.

**broader_coq_strategy:** Treats Cell 7 as an isolated investment without connecting to broader COQ improvement strategy. Does not propose a systematic approach to address the remaining $1.03M in internal failures beyond Cell 7, nor does it outline a prevention-focused strategy to rebalance the COQ distribution from the current failure-heavy structure to a prevention-focused approach.

---

### QNC-025: PPAP submission with marginal capability data

**Difficulty:** medium | **Category:** regulatory-compliance | **Score:** 32.5%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| ppap_strategy | 0.35 | fail | 0.0 |
| customer_communication | 0.35 | partial | 0.5 |
| technical_accuracy | 0.3 | partial | 0.5 |

**ppap_strategy:** The agent recommends requesting a 2-day extension to delay the PPAP submission, which directly contradicts standard PPAP practice. The correct approach is to submit on time with current data and a corrective action plan for interim approval. The agent's primary recommendation would cause the customer to miss their program timeline, which is exactly what automotive PPAP process is designed to avoid through interim approvals with corrective actions.

**customer_communication:** The agent correctly recommends proactive customer contact with transparency about the Ppk gap (1.42 vs 1.67) and identifies the root cause (pilot pin alignment). However, the communication strategy focuses on requesting an extension rather than proposing the standard interim approval approach with corrective action plan. The agent does include key messaging elements but misses the critical ask for 'interim approval with corrective action plan.'

**technical_accuracy:** The agent correctly identifies the Ppk vs Cpk difference (1.42 vs 1.58) and notes that Cpk shows 'process centering capability,' which demonstrates some understanding of the statistical relationship. However, the response lacks critical technical details: no recommendation for 100% inspection as interim containment, no specification that a full new 125-piece capability study is needed after the die fix (not just an extension), and doesn't explain how pilot pin alignment affects between-subgroup variation specifically.

---

### QNC-026: Process validation deviation discovered retroactively in pharmaceutical manufacturing

**Difficulty:** hard | **Category:** regulatory-compliance | **Score:** 72.5%

| Criterion | Weight | Rating | Score |
|---|---|---|---|
| validation_impact_assessment | 0.3 | partial | 0.5 |
| product_risk_assessment | 0.25 | pass | 1.0 |
| regulatory_strategy | 0.25 | partial | 0.5 |
| corrective_actions | 0.2 | pass | 1.0 |

**validation_impact_assessment:** The response correctly identifies that the process validation is compromised due to systematic measurement error and that actual operating conditions don't match documented parameters. However, it makes an overly broad declaration that the validation is 'INVALID' and requires revalidation without adequately considering that the process operated consistently at 12.7-13.7kN and all quality tests passed. The response mentions retrospective validation as an option but doesn't properly assess whether the validation conclusion (process produces consistent, conforming product) may still be valid with corrected documentation. It misses the key nuance that a bridging study might be sufficient rather than full revalidation.

**product_risk_assessment:** The response correctly assesses product risk as MEDIUM-LOW mitigated by passing quality tests. It specifically notes that all 48 lots passed dissolution and content uniformity testing, acknowledges consistent operation within a narrow actual range (12.7-13.7kN), identifies potential concerns about tablet hardness/friability at lower compression forces, and concludes patient safety risk is LOW based on passing release testing. The assessment appropriately uses the quality data as the primary risk indicator while noting areas requiring verification.

**regulatory_strategy:** The response outlines a regulatory approach including deviation reporting, impact assessment, and proactive disclosure preparation. It mentions FDA Field Alert Report considerations and change control initiation. However, it doesn't clearly assess whether the 48 conforming lots require field action (they don't based on quality data), and the timeline structure is somewhat unclear. The response mentions preparing for regulatory disclosure but doesn't emphasize the importance of proactive disclosure to FDA at next inspection with supporting quality data demonstrating the lots' acceptability.

**corrective_actions:** The response provides comprehensive corrective actions addressing both immediate and systemic issues: (1) immediate calibration correction with certified reference standards, (2) retrospective validation through expanded testing and statistical analysis, (3) systematic enhancements including calibration program improvements, enhanced process monitoring, and preventive measures. The phased approach covers calibration correction, batch investigation, retrospective validation, process characterization, and system enhancement. The actions appropriately address the gap between calibration and validation programs.

---
